Pfizer (PFE) – FDA News
-
Pfizer (PFE) Announces EC Approves EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options
-
Pfizer RSV shot meets goals in trial of high-risk adults under age 60
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PFE Stock Lookup